| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.42▲ | 3.43▼ | 3.42▼ | 3.36▲ | 3.30▲ |
| MA10 | 3.44▼ | 3.39▲ | 3.36▲ | 3.46▼ | 3.87▼ |
| MA20 | 3.39▲ | 3.38▲ | 3.45▼ | 3.27▲ | 5.80▼ |
| MA50 | 3.47▼ | 3.37▲ | 3.34▲ | 4.11▼ | 19.92▼ |
| MA100 | 3.35▲ | 3.37▲ | 3.51▼ | 5.99▼ | 28.09▼ |
| MA200 | 3.68▼ | 4.74▼ | 5.18▼ | 13.10▼ | 35.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.008▲ | -0.004▼ | 0.091▲ | 0.638▲ |
| RSI | 50.375▲ | 50.791▲ | 50.376▲ | 46.701▼ | 26.875▼ |
| STOCH | 33.916 | 73.178 | 65.933 | 54.911 | 10.103▼ |
| WILL %R | -63.636 | -37.500 | -33.333 | -41.085 | -86.029▼ |
| CCI | -17.646 | 59.649 | 50.375 | 33.313 | -66.218 |
|
Thursday, November 19, 2026 04:44 AM
Clinical-stage biotechnology company Immutep Limited (NASDAQ:IMMP) announced Phase 2 data showing an 81.1% 12-month disease-free survival rate for its combination regimen in high-risk, resectable soft ...
|
|
Wednesday, November 18, 2026 11:44 PM
Immutep Limited (NASDAQ: IMMP) presented new survival data from its EFTISARC-NEO Phase II trial at the Connective Tissue Oncology Society 2026 Annual Meeting, showing a 12-month disease-free survival ...
|
|
Wednesday, November 18, 2026 04:01 PM
Poster presented today at CTOS 2026 expands on the survival data first reported in the abstract (announced 11 November 2026), which showed a 12-month disease-free survival (DFS) of 81.1% in patients ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/11/26 | 3.31 | 3.57 | 3.31 | 3.42 | 82,876 |
| 18/11/26 | 3.16 | 3.4999 | 3.06 | 3.25 | 138,152 |
| 17/11/26 | 3.39 | 3.39 | 3.163 | 3.26 | 6,833 |
| 16/11/26 | 3.41 | 3.50 | 3.20 | 3.40 | 26,679 |
| 13/11/26 | 3.65 | 3.76 | 3.4221 | 3.48 | 14,849 |
| 12/11/26 | 3.30 | 3.95 | 3.30 | 3.655 | 61,541 |
| 11/11/26 | 3.69 | 3.74 | 3.43 | 3.56 | 58,707 |
| 10/11/26 | 3.63 | 3.69 | 3.40 | 3.46 | 81,308 |
| 09/11/26 | 3.62 | 3.92 | 3.6068 | 3.80 | 65,950 |
| 06/11/26 | 2.69 | 3.49 | 2.69 | 3.34 | 97,169 |
|
|
||||
|
|
||||
|
|